Bioinformatics prediction of function of T-cell exhaustion related genes in ischemic stroke

利用生物信息学方法预测缺血性卒中中T细胞耗竭相关基因的功能

阅读:1

Abstract

Ischemic stroke (IS) is a multifactorial disease caused by the interaction of a variety of environmental and genetic factors, which can lead to severe disability and heavy social burden. This study aimed to find potential biomarkers related to T cell exhaustion (TEX) in IS. Based on the GSE16561 dataset, differentially expressed genes (DEGs) were screened from IS and control groups, and their enriched biological pathways were explored. The TEX enrichment score for each sample was calculated using the GSEA algorithm, and the gene modules with the highest correlation with the TEX score were screened by WGCNA. Then, two machine learning algorithms were used to screen the key genes and test the correlation between the key genes and the level of immune cell infiltration. Potential drugs or molecular compounds that interact with key genes were predicted by searching DGIdb, and the drug-gene interaction network was visualized by Cytoscape software. Using GSE16561 dataset, we performed differential expression analysis and identified 482 DEGs. By weighted gene co-expression network analysis (WGCNA) and machine learning algorithms, we identified five key genes: CD163, LAMP2, PICALM, RGS2 and PIN1. Functional enrichment analysis revealed that these genes were involved in immune response and cellular processes, which were closely related to the level of immune cell infiltration. In addition, potential drug interactions were predicted using the drug-Gene Interaction database, providing avenues for future therapeutic strategies. This study enhances the understanding of TEX-related biomarkers in ischemic stroke and provides insights into the development of novel interventions aimed at improving patient outcomes.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。